Rogier Q Hintzen
Overview
Explore the profile of Rogier Q Hintzen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
2858
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mescheriakova J, van Nierop G, van der Eijk A, Kreft K, Hintzen R
Neurol Neuroimmunol Neuroinflamm
. 2020 Aug;
7(6).
PMID: 32796079
Objective: In multiplex MS families, we determined the humoral immune response to Epstein-Barr virus nuclear antigen 1 (EBNA-1)-specific immunoglobulin γ (IgG) titers in patients with MS, their healthy siblings, and...
2.
Rijvers L, Melief M, van Langelaar J, van der Vuurst de Vries R, Wierenga-Wolf A, Koetzier S, et al.
J Immunol
. 2020 Jul;
205(4):945-956.
PMID: 32641384
C-type lectin is located next to , the master transcription factor of HLA class II (HLA-II), at a susceptibility locus for several autoimmune diseases, including multiple sclerosis (MS). We previously...
3.
Bruijstens A, Wong Y, van Pelt D, van der Linden P, Haasnoot G, Hintzen R, et al.
Neurol Neuroimmunol Neuroinflamm
. 2020 Mar;
7(3).
PMID: 32198229
Objective: To investigate the possible human leukocyte antigen (HLA) association of both myelin oligodendrocyte glycoprotein (MOG-IgG)-associated diseases (MOGAD) and aquaporin-4 antibody (AQP4-IgG)-positive neuromyelitis optica spectrum disorders (NMOSDs) in the Dutch...
4.
de Mol C, Jansen P, Muetzel R, Knol M, Adams H, Jaddoe V, et al.
Ann Neurol
. 2020 Mar;
87(5):774-787.
PMID: 32162725
Objective: Multiple sclerosis (MS) is a neurological disease with a substantial genetic component and immune-mediated neurodegeneration. Patients with MS show structural brain differences relative to individuals without MS, including smaller...
5.
de Bruijn M, Bruijstens A, Bastiaansen A, van Sonderen A, Schreurs M, Sillevis Smitt P, et al.
Neurol Neuroimmunol Neuroinflamm
. 2020 Feb;
7(3).
PMID: 32047077
Objective: The aims of this study were (1) to describe the incidence of autoimmune encephalitis (AIE) and acute disseminated encephalomyelitis (ADEM) in children, (2) to validate the currently used clinical...
6.
Wong Y, Bruijstens A, Barro C, Michalak Z, Melief M, Wierenga A, et al.
Neurology
. 2019 Aug;
93(10):e968-e974.
PMID: 31383792
Objective: To explore the correlation between serum and CSF neurofilament light chain (NfL) and the association of NfL levels and future disease activity in pediatric patients with a first attack...
7.
van Langelaar J, Rijvers L, Janssen M, Wierenga-Wolf A, Melief M, Siepman T, et al.
Ann Neurol
. 2019 May;
86(2):264-278.
PMID: 31136008
Objective: Results from anti-CD20 therapies demonstrate that B- and T-cell interaction is a major driver of multiple sclerosis (MS). The local presence of B-cell follicle-like structures and oligoclonal bands in...
8.
van der Vuurst de Vries R, Hintzen R
JAMA Neurol
. 2019 Mar;
76(5):623-624.
PMID: 30830147
No abstract available.
9.
Wong Y, de Mol C, van der Vuurst de Vries R, van Pelt E, Ketelslegers I, Catsman-Berrevoets C, et al.
Neurol Neuroimmunol Neuroinflamm
. 2019 Jan;
6(2):e528.
PMID: 30697581
Objective: To compare the diagnostic accuracy of the McDonald 2017 vs the McDonald 2010 criteria to predict a second attack of MS (clinically definite MS [CDMS]) at the first attack...
10.
Hintzen R
Lancet Child Adolesc Health
. 2018 Sep;
2(3):161-162.
PMID: 30169249
No abstract available.